Role of hospital-based cancer registry in planning the cancer control program in semiurban setting in Alandi, Pune, Maharashtra, India.

e22566 Background: Indrayani Hospital and Cancer Institute (IHCI) in Maharashtra, India, has provided comprehensive cancer care to underserved populations since 2008. In 2020, IHCI established a Hospital-Based Cancer Registry (HBCR) to systematically document cancer burden and treatment patterns. The objective of the study is to showcase how HBCR data is leveraged to plan cancer control activities, specifically developing an Early Detection Program (EDP) for oral, breast, and cervical cancers, which are the most prevalent cancers in India. Methods: The HBCR analyzed registered cases from 2019 to 2023. Clinical and demographic data were coded using ICD-O3 and analyzed using CanReg5 and STATA. Trends in incidence, disease stage, and treatment outcomes were studied to identify care delivery gaps and guide early detection strategies. Based on HBCR finding the technical committee felt the need for raising cancer awareness on the commonly occurring cancers. Results: From 2019 to 2023, 7,810 cancer cases were registered, with 3,788 males and 4,022 females. Oral cancer was the leading cancer among males (1,667; 44%), while breast cancer was predominant among females (1,196; 30%). Tobacco-related cancers accounted for 66% (2,500) of male cases. Approximately 93% (3,730) of oral, breast, and cervical cancer cases presented at loco-regional stages, underscoring the necessity of early detection. Treatment completion rates were 70% (5,430), and 87% (6,799) of patients benefited from financial support through the Mahatma Jyotiba Phule Jan Arogya Yojana (MJPJAY). Conclusions: HBCR data offered vital epidemiological insights, shaping a comprehensive EDP modeled on the TMC Sangrur 1 initiative. The program incorporates community-based selective screening for oral, breast, and cervical cancers, capacity building for primary care providers, and alignment with public health infrastructure. This study underscores the significance of registry-driven evidence in cancer prevention and control strategies in resource-limited settings.